SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon reports 55% fall in Q4 consolidated net profit

25 Apr 2014 Evaluate

Biocon has reported results for fourth quarter and year ended March 31, 2014

The company has posted a rise of 126.53% in its net profit at Rs 86.74 crore for the quarter ended March 31, 2014 as compared to Rs 38.29 crore for the same quarter in the previous year. Total income of the company has increased by 20.25% at Rs 582.53 crore for quarter under review as compared to Rs 484.40 crore for the quarter ended March 31, 2013.

On consolidated basis, the company has reported 54.51% fall in its net profit at Rs 113.08 crore for the quarter ended March 31, 2014 as compared to Rs 248.61 crore for the same quarter in the previous year. However, total income of the company has soared by 14.92% at Rs 745.77 crore for quarter under review as compared to Rs 648.93 crore for the quarter ended March 31, 2013.

For the year ended March 31, 2014, the group has posted a jump of 19.64% in its net profit at Rs 329.85 crore as compared to Rs 275.7 crore for the same period in the previous year. Total income of company has surged by 13.75% at Rs 2263.08 crore for year under review as compared to Rs 1989.47 crore for the period ended March 31, 2013.

For the year ended March 31, 2014, on the consolidated basis, the group has reported 18.69% fall in its net profit at Rs 413.72 crore as compared to Rs 508.82 crore for the same period in the previous year. However, total income of company has increased by 15.57% at Rs 2933.19 crore for year under review as compared to Rs 2537.96 crore for the period ended March 31, 2013.

Biocon Share Price

363.50 5.00 (1.39%)
21-Apr-2026 10:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.90
Dr. Reddys Lab 1224.25
Cipla 1232.55
Zydus Lifesciences 930.50
Lupin 2326.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×